ea0010ds5 | Cell therapy to cure | SFE2005
Amiel S
Patients with diabetes are well aware that their risk of long-term complications is minimised by the maintenance of near-normoglycaemia. Intensive therapy regimens designed to achieve this in people with insulin deficient diabetes (Type 1 and late Type2) require detailed understanding of the actions of insulin preparations and their interaction with food and daily activities, multiple daily injections and frequent self monitoring of blood glucose concentrations. There is the e...